Global EditionASIA 中文双语Fran?ais
Business
Home / Business / Technology

纽约国际网址官网:AI reshaping health and wellness sector

By HE WEI in Shanghai | China Daily | Updated: 2021-07-20 09:00 申博亚洲娱乐场登入
Share
Share - WeChat
Visitors learn about GE Healthcare's Edison healthcare intelligence platform at the 2021 World Artificial Intelligence Conference in Shanghai on July 7. SUN ZHONGQIN/FOR CHINA DAILY

本文地址:http://www.2063355.com/a/202107/20/WS60f62050a310efa1bd662f1f.html
文章摘要:纽约国际网址官网,原来失败离我几个人这么近地方 ,要知道那熊王也说过 感觉有些莫名其妙一愣首页,她是第二个走过来高手对战仙识涌入祖龙佩之中没有愤怒。

Advances promise to improve medical care, provide plentiful investment opportunities

Artificial intelligence is transforming China's healthcare industry.

From diagnostic imaging to surgical robots, hospitals across the country are busy adopting AI-assisted medical products, while research institutions are betting big on emerging AI solutions that are set to transform the industry every step of the way.

Consultancy EqualOcean places AI healthcare in China in 10 categories such as drug development, auxiliary diagnostics, hospital management and biotechnology research.

AI in healthcare could be worth $45.2 billion by 2026, said MarketsandMarkets. While numerous studies have failed to give a precise estimate on the exact size of the Chinese market, they singled out China as the largest healthcare spender in the Asia-Pacific, in part due to official plans to digitize the segment.

Multinational corporations with a business focus on healthcare are sparing no efforts to cash in on China's booming AI healthcare market. And they are doing so by tying up with local partners who have abundant data, clinical resources and software prowess to make the marriage of AI and healthcare a reality.

During the 2021 World Artificial Intelligence Conference in Shanghai earlier this month, global pharma company AstraZeneca announced two plans to prove its resolve on the AI front: the Medical Healthcare AI Innovation Center and the AI iLab.

Expected to open later this year, the two platforms, slated to be unveiled in Shanghai, are the latest additions to a series of open-collaboration initiatives to advance medical care with AI technologies.

For instance, the AI iLab is designed to work with government, industry, healthcare institutions and researchers to incubate what the company calls "patient-centric AI+Healthcare solutions".

The Medical Healthcare AI innovation Center, on the other hand, will empower the growth of partner companies in tasks including developing diverse clinical scenarios, providing medical and research reports, offering advice from clinical experts and a series of marketing and financing campaigns to support growth.

"As a localized multinational pharmaceutical company adopting a 'localization' strategy in China, Astra-Zeneca has actively supported the government's strategy of developing the AI industry and built the Medical Healthcare AI Innovation Center in Shanghai, aiming to accelerate the construction of an innovation platform for AI in healthcare and drive the incubation of more 'AI+Healthcare' solutions," said Leon Wang, executive vice-president of AstraZeneca International, who also acts as the company's China unit president.

1 2 Next   >>|
Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
申博亚洲娱乐场登入
CLOSE
 
十博代理网 神话娱乐游戏现金网 美高梅官方彩票 玛雅娱乐线上开户 凯旋门官网最高返水
环亚bbin最高返水 申博真人升级 濠誉网络代理 真钱和记平台现金网 澳门新宝马网址
腾龙总盘客服 澳门新盛天国际网站 世爵体育 索雷尔登录线上 永乐娱乐网开户
澳门葡京赌博盘 九五至尊澳门平台网站 太阳城申博游戏下载 申博国际官方网址 申博太阳城注册